首页|痰中性粒细胞数量和结核分枝杆菌载量预测肺结核患者强化治疗的反应

痰中性粒细胞数量和结核分枝杆菌载量预测肺结核患者强化治疗的反应

扫码查看
目的 探讨痰涂片阳性肺结核(PTB)患者中痰中性粒细胞(PMNs)数量、结核分枝杆菌载量与抗结核强化治疗反应的关系。方法 回顾性收集2021年1-12月陕西省结核病防治院患者,以痰未转阴组为病例组,痰转阴组为对照组,分析新发PTB患者痰PMNs数量、结核分枝杆菌载量和其他因素的治疗前后水平。结果 与痰未转阴组比较,痰转阴组患者治疗前PMNs数量、显微镜下结核分枝杆菌以及痰涂片抗酸杆菌(AFB)镜检分级、痰GeneXpert测定的载量更低,而痰GeneXpert测定的Probe B循环阈值(Xpert-Probe B-Ct)更高(P<0。05)。Xpert-Probe B-Ct值与AFB显微镜测定的相应痰样本中的结核分枝杆菌载量显著相关(rs=-0。77,P<0。001)。在受试者操作特征曲线分析中,痰PMNs对痰转阴延迟的预测效能最高,Xpert-Probe B-Ct值次之,镜检下痰结核分枝杆菌载量最差,曲线下面积分别为0。852、0。784、0。669。根据多因素回归模型校正,痰PMNs数量、GeneXpert测定的痰结核分枝杆菌载量可能是影响临床抗结核治疗反应的主要因素(P<0。05)。结论 治疗前痰PMNs数量和GeneXpert测定的痰结核分枝杆菌载量具有成为预测PTB患者强化治疗后治疗反应标志物的潜力。
Effectiveness of the neutrophil number and mycobacterium tuberculosis load in sputum in predicting intensive treatment response in pulmonary tuberculosis patients
Objective To investigate the relationship between the sputum polymorphonuclear neutrophils(PMNs)count,the load of mycobacterium tuberculosis and the response to anti-tuberculosis intensive therapy in patients with sputum smear-positive pulmonary tuberculosis(PTB).Methods This is a retrospective case-control study completed in Shaanxi Provincial Tuberculosis Prevention Hospital from January to December 2021.Included were cases(sputum non-conversion group)who were≥18 years old with newly diagnosed PTB(sputum smear positive,rifampicin-sensitive),treated with the World Health Organization standard proto-col(fixed dose)for 2 months(intensive phase),and did not convert their sputum smear to negative.The inclu-sion criteria for the control group(sputum conversion group)were similar to those in the case group,except that sputum conversion was observed at the end of intensive treatment.Pretreatment levels of sputum PMNs,mycobacterium tuberculosis and other factors in patients with new-onset PTB were retrospectively analyzed.Results Compared with the case group,the number of PMNs and microscopic sputum mycobacterium tuber-culosis,AFB microscopic grading,load measured by sputum GeneXpert(Xpert-Probe B-Ct)in the control group were significantly lower,and Probe B cycle threshold and load measured by sputum GeneXpert(Xpert-Probe B-Ct)in the control group was higher(P<0.05).Xpert-Probe B-Ct value was significantly correlated with the mycobacterium tuberculosis in the corresponding sputum sample measured by AFB microscopy(r =-0.77,P<0.001).In the analysis of the receiver operating characteristic(ROC)curve,sputum PMNs had the highest predictive effect on sputum conversion delay,followed by GeneXpert-Probe B-Ct value and the load of sputum mycobacterium tuberculosis under microscopic examination,with areas under the curve(AUC)of 0.852,0.784 and 0.669,respectively.According to the multivariate regression model correction,number of sputum PMNs,and sputum mycobacterium tuberculosis measured by GeneXpert might be the main factors affecting the response of clinical anti-tuberculosis treatment(P<0.05).Conclusion The numbers of sputum PMNs before treatment and the sputum mycobacterium tuberculosis measured by GeneXpert have the potential of being markers for predicting post-intensive treatment response in PTB patients.

polymorphonuclear neutrophilsmycobacterium tuberculosis loadpulmonary tuberculosisre-sponse to intensive treatment

董珍、王婉如、卢琼

展开 >

陕西省结核病防治院(陕西省第五人民医院) 内五科,陕西 西安 710100

中性粒细胞 结核分枝杆菌载量 肺结核 治疗反应

陕西省卫生健康科研基金

2018D046

2024

兰州大学学报(医学版)
兰州大学

兰州大学学报(医学版)

CSTPCD
影响因子:0.641
ISSN:1000-2812
年,卷(期):2024.50(1)
  • 21